PROTECH HOME MEDICAL ANNOUNCES COMMENCEMENT OF TRADING ON THE OTCQX® BEST MARKET IN THE UNITED STATES
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.
Cincinnati, Ohio – June 2, 2020 – Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV: PTQ) (OTCQX: PTQQF), a healthcare services company with operations in the U.S., today announced that it has qualified to trade on the OTCQX® Best Market.
The common shares of Protech will
commence trading at the open today on OTCQX under the symbol “PTQQF.” U.S.
investors can find current financial disclosure and Real-Time Level 2 quotes
for the company on www.otcmarkets.com.
The OTCQX Best Market provides value and convenience
to U.S. investors, brokers and institutions seeking to trade PTQQF. The OTCQX
Best Market is OTC Markets Group's premier market for established,
investor-focused U.S. and international companies. Trading on the OTCQX Market
is intended to offer companies efficient, cost-effective access to the U.S.
capital markets. For companies listed on a qualified international exchange,
streamlined market standards enable them to utilize their home market reporting
to make their information available in the U.S. To qualify for OTCQX, companies
must also meet high financial standards, follow best practice corporate
governance, and demonstrate compliance with applicable securities laws.
Information relating to the
Company, including copies of the Company’s financial statements, are available
on SEDAR at www.sedar.com.
“We are extremely proud to announce the commencement
of trading on the OTCQX Best Market,” said
Greg Crawford, CEO and Chairman of Protech. “This is a true milestone for our
Company, and we are thrilled to have a foundation in which we can share our
long-term vision for Protech with a wider pool of retail and institutional
shareholders throughout the United States. We firmly believe that cross-trading
on OTCQX in the U.S. is vital for a company headquartered in the U.S. and
deriving 100% of its revenue from U.S. customers. I believe this is the first
step towards fulfilling our ambitions of a dual listing on the NASDAQ or NYSE.”
Protech’s Chief Financial Officer,
Hardik Mehta added, “We are in the process of obtaining DTC eligibility,
and will keep our shareholders updated when this process is concluded. DTC
eligibility would simplify the process for investors and brokers trading and
exchanging our stock in the United States, which will be of significant benefit
to our current and future shareholders. I also expect that being DTC eligible
will improve our overall liquidity over time and help to accelerate the
broadening of our shareholder base in North America over time.”
“We are pleased to welcome Protech
Home Medical to the OTCQX Best Market,” said Jason Paltrowitz, EVP of Corporate
Services at OTC Markets Group. “I believe that trading on the TSX Venture
Exchange in Canada and on the OTCQX Market in the U.S. will enable Protech Home
Medical to more efficiently build global investor awareness. We look forward to
supporting the company and its shareholders.”
Protech provides home delivery and efficient
online set-up of equipment for, primarily, chronic conditions. The Company,
based in the United States, operates out of 42 locations in 10 states with over
17,000 referring physicians and approximately 85,000 current active patients.
Protech is also pleased to advise
that B. Riley FBR, Inc. acted as its OTCQX sponsor. B. Riley FBR, is a
full-service investment bank and subsidiary of B. Riley Financial, Inc. B.
Riley FBR, based in Los Angeles with offices across the United States, provides
corporate finance, research, sales and trading services.